Applonia Rose, Managing Editor at Sage Publishing, shared an article by Rami Yanes, et al. on LinkedIn:
“New Review on Circulating Tumor DNA in Early-Stage Colon Cancer:
Explore the latest review article published in Technology in Cancer Research & Treatment (TCRT), on the prognostic and predictive value of circulating tumor DNA (ctDNA) in early-stage colon cancer. With ctDNA emerging as a promising biomarker, this review examines recent findings, clinical implications and future research needs.
It was a great experience working with Dr. Ibrahim Halil Sahin on this insightful piece. Rami Yanes; University of Pittsburgh School of Medicine.
Read the full article here.”
Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer.
Authors: Rami Yanes, et al.
